pharmaceutical-investing Auris Medical Receives Positive Scientific Advice from EMA on Development Plan and Regulatory Pathway for AM-111
pharmaceutical-investing Clementia Initiates Phase 2 MO-Ped Trial for Palovarotene in Patients with Multiple Osteochondromas
pharmaceutical-investing Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results
pharmaceutical-investing CytomX Therapeutics Announces Full-Year 2017 Financial Results and Provides Operational Update
Aptose Biosciences Announces Exclusive License Agreement for Dual BET/Kinase Targeting Program With OHM Oncology
Juggernaut Announces Fully Funded 10,000 Meter Inaugural Drill Program on New District-Scale Gold Silver Copper Rich System at 100% Controlled Big One Property, Golden Triangle, B.C.
SAGA Metals Confirms Significant High-Grade Mineralization at Trapper North Releasing Additional Assays at Radar Critical Minerals Project in Labrador
